Showing results (31-40 of 36) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
AIDS (London, England)|December 15, 2017
Switch from tenofovir disoproxil fumarate combination to dolutegravir with rilpivirine improves parameters of bone healthGrace A McComsey, Sergio Lupo, David Parks, et al.Science (New York, N.Y.)|March 18, 2017
Revealing the subfemtosecond dynamics of orbital angular momentum in nanoplasmonic vorticesG Spektor, D Kilbane, A K Mahro, et al.Lancet (London, England)|January 10, 2018
Efficacy, safety, and tolerability of dolutegravir-rilpivirine for the maintenance of virological suppression in adults with HIV-1: phase 3, randomised, non-inferiority SWORD-1 and SWORD-2 studiesJosep M Llibre, Chien-Ching Hung, Cynthia Brinson, et al.Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|September 14, 2012
Azole-resistant invasive aspergillosis in a patient with acute myeloid leukaemia in GermanyA Hamprecht, D Buchheidt, J J Vehreschild, et al.The Lancet. HIV|July 17, 2019
Efficacy and safety of dolutegravir-rilpivirine for maintenance of virological suppression in adults with HIV-1: 100-week data from the randomised, open-label, phase 3 SWORD-1 and SWORD-2 studiesMichael Aboud, Chloe Orkin, Daniel Podzamczer, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|July 18, 2020
Brief Report: Durable Suppression and Low Rate of Virologic Failure 3 Years After Switch to Dolutegravir + Rilpivirine 2-Drug Regimen: 148-Week Results From the SWORD-1 and SWORD-2 Randomized Clinical TrialsJean van Wyk, Chloe Orkin, Rafael Rubio, et al.Pageof 4